Track topics on Twitter Track topics that are important to you
The Cambridge-based biotech announced plans for a proposed $225 million stock offering to fund further clinical testing on and production of eteplirsen.
Original Article: FDA approval in hand, Sarepta plans for future studiesNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...